Top-News
Montag,
08.10.2018 15:05
von
PR Newswire
| Aufrufe: 270
Introducing No7 Laboratories Line Correcting Booster Serum, the NEW non-invasive wrinkle solution, clinically proven to reduce the appearance of wrinkles by up to 5 years in 12 weeks
Labormitarbeiter bei der Arbeit. (Symbolbild).
© sanjeri / E+ / Getty Images
http://www.gettyimages.de
PR Newswire
NEW YORK, Oct. 8, 2018
NEW YORK, Oct. 8, 2018 /PRNewswire/ -- Today, No7 announced the launch of its first product in the new No7 Laboratories line-up of targeted skincare solutions: No7 Laboratories Line Correcting Booster Serum, exclusively available at Walgreens.com as of today and in Walgreens stores nationwide on November 4, 2018. This new fast acting non-invasive solution is clinically proven to reduce the appearance of wrinkles by up to 5 years in as little as 12 weeks1. Clinical studies show that women who tested the product experienced a reduction in the appearance of their deepest, most stubborn lines and wrinkles.
"No7 Laboratories Line Correcting Booster Serum is the first innovation launched under the No7 Laboratories brand, a new type of skincare, benefiting from No7 deep expertise, that pushes the boundaries of efficacy to deliver results that rival professional grade treatments," said Hillary Hutcheson, U.S. Senior Marketing Director for No7. "We're thrilled to introduce this ground-breaking innovation in the U.S. This new serum generated a 17,000 person-waitlist when it launched in the U.K., and we anticipate similar excitement here in the U.S."
This new clinically proven targeted booster serum is No7's most concentrated age-defying solution and the first specifically designed to be applied directly to the lines and wrinkles where women want to see the most results. In fact, consumer studies showed that women said No7 Laboratories Line Correcting Booster Serum was the best result they had ever seen from an age-defying product2&3.
The secret to the formula lies in No7's powerful anti-wrinkle peptide technology, Matrixyl 3000 PlusTM 4, which helps skin recover some of its key properties and components, such as elastic fibrillin that is lost early in the aging process and gives rise to lines and wrinkles. No7 Laboratories Line Correcting Booster Serum contains much higher concentrations of Matrixyl 3000 PlusTM, seven times in fact, to maximize its fibrillin repair capabilities.
Developed to be used in addition to your favorite No7 serum and moisturizer, the No7 Laboratories Line Correcting Booster Serum will help your skin experience an extraordinary transformation, ensuring you continue to give your skin its best possible daily care and age-defying support.
Consumer trials showed the following2:
ARIVA.DE Börsen-Geflüster
Werbung
Weiter aufwärts?
| Kurzfristig positionieren in Walgreens Boots Alliance Inc | ||
|
VM18RP
| Ask: 0,11 | Hebel: 4,04 |
| mit moderatem Hebel |
Zum Produkt
| |
Vontobel
Den Basisprospekt sowie die Endgültigen Bedingungen und die Basisinformationsblätter erhalten Sie hier: VM18RP,. Beachten Sie auch die weiteren Hinweise zu dieser Werbung. Der Emittent ist berechtigt, Wertpapiere mit open end-Laufzeit zu kündigen.
Kurse
 |
- Week 1: a visible reduction in the appearance of lines and wrinkles on the forehead and around the eyes
- Week 2: visible improvements in six targeted wrinkle areas:
- Forehead
- Crow's feet
- Lips
- Between brows
- Under eyes
- Nasolabial folds
Among women who were considering Botox3, 77% of women said the serum gave them better results than they thought possible from skincare after testing the product for 2 months and 73% said they were less likely to consider Botox in the future.
Of those that had already had Botox3, 80% of women said the serum gave them better results than they thought possible from skincare and 73% said they would delay their next treatment.
No7 Laboratories Line Correcting Booster Serum is priced at $41.99 and is available exclusively at Walgreens.com starting October 8, 2018 and in Walgreens stores nationwide starting November 4, 2018.
No7 Laboratories Line Correcting Booster Serum will also be available online and in stores nationwide at Target and Ulta on January 1, 2019.
For more information, please contact:
Emma.Maliszewski@bm.com; Beatrice.Jimenez@bm.com
About No7 Laboratories
No7 Laboratories represents No7's commitment to investing in ground-breaking research and development as a direct response to the ever-changing needs of its millions of customers every day.
Acknowledging that skincare concerns are deeply individual and often require treatments that go beyond everyday skincare, No7 Laboratories offers a suite of powerful, fast acting tools to help you target the skin concerns that matter most to you, delivering dramatic, visible results that are better than you thought possible from skincare alone.
About No7
Launched in the U.K. in 1935, the No7 brand has been rewriting beauty history for over 80 years, with the aim of helping women look and feel their best every day. The No7 team continues to invest in ground-breaking research and development, responding to the ever-changing needs of its millions of customers every day. From No7's range of clinically proven age-defying serums, to the breakthrough No7 Match Made service, No7 customers believe in the power of our products as much as we do.
No7 sits within the Global Brands portfolio of Walgreens Boots Alliance, Inc. (Nasdaq: WBA), the first global pharmacy-led, health and wellbeing enterprise.
@No7USA
#No7Laboratories
1 Clinical study on 31 women
2 Tested on 98 women in a consumer study over 8 weeks
3 Tested on 81 women in a consumer study considering Botox and 30 women who have had Botox over 8 weeks
4 Matrixyl 3000 Plus is a trademark of Sederma
View original content to download multimedia:http://www.prnewswire.com/news-releases/introducing-no7-laboratories-line-correcting-booster-serum-the-new-non-invasive-wrinkle-solution-clinically-proven-to-reduce-the-appearance-of-wrinkles-by-up-to-5-years-in-12-weeks-300726719.html
SOURCE No7
Werbung
Mehr Nachrichten zur Walgreens Boots Alliance Inc Aktie kostenlos abonnieren
E-Mail-Adresse
Bitte überprüfe deine die E-Mail-Adresse.
Benachrichtigungen von ARIVA.DE
(Mit der Bestellung akzeptierst du die Datenschutzhinweise)
(Mit der Bestellung akzeptierst du die Datenschutzhinweise)
-1
Vielen Dank, dass du dich für unseren Newsletter angemeldet hast. Du erhältst in Kürze eine E-Mail mit einem Aktivierungslink.
Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.
